Background: Many patients evaluated for acute coronary syndrome (ACS) in emergency departments (EDs) continue to experience troubling symptoms after discharge-regardless of their ultimate medical diagnosis. However, comprehensive understanding of common post-ED symptom trajectories is lacking.
of this exploratory investigation were to increase understanding of these symptom trajectories, generate further testable hypotheses, and inform education for patients and healthcare providers about symptom trajectories after hospital discharge.
BACKGROUND Symptoms Associated With ACS
A variety of physical symptoms may trigger suspicion for ACS, including "classic" symptoms of chest pain or discomfort, discomfort in other areas of the upper body, shortness of breath, sweating, nausea, and light-headedness as well as less typical symptoms of fatigue, palpitations, indigestion, and pain in other areas (Canto et al., 2012; DeVon, Ryan, Ochs, & Shapiro, 2008; El-Menyar et al., 2011; Go et al., 2014; McSweeney, O'Sullivan, Cody, & Crane, 2004) . These symptoms are distressing both for patients ruled in and ruled out for ACS. All patients with such symptoms require treatment, support, and education regardless of their ultimate medical diagnoses.
Significance of Post-ED Symptoms
The great majority of patients ruled in and ruled out for ACS are eventually discharged home-either from the ED or from inpatient units-but little is known about their symptoms after discharge (Barnason et al., 2012) . This knowledge gap results in periods where patients are undersupported, undereducated, and undertreated (Naylor, Aiken, Kurtzman, Olds, & Hirschman, 2011) . Unmet needs, including lack of education and unmanaged symptoms, are associated with high rates of repeat ED use for both patients with and without an ACS diagnosis (LeClerc, Wells, Craig, & Wilson, 2002; Vashi et al., 2013) . These patients' symptom burdens are also associated with decreased quality of life (Karlson, Währborg, Sjöland, Lindqvist, & Herlitz, 1998) .
Current evidence suggests that patients with myocardial infarction (MI)-a subset of patients with ACS-are especially vulnerable to readmission: Nearly 20% of patients with MI are readmitted within 30 days of discharge. However, only 10% of these readmissions result in a primary diagnosis of MI (Dharmarajan et al., 2013) . This evidence suggests that post-ED symptoms, in addition to reducing quality of life, may reflect a variety of disease processes requiring intervention.
Symptom Trajectories
The role of symptoms in patients' quality of life and functional status has been identified as a key area of inquiry to support high-quality, patient-centered healthcare (Rumsfeld et al., 2013) . However, most ACS symptom research to date has been cross-sectional (Arslanian-Engoren et al., 2006) . Because patients frequently experience ongoing or recurrent symptoms after an ED visit or hospitalization, a truly patient-centered approach requires understanding individual symptom trajectories. A symptom trajectory is defined as a pattern of symptoms over time (Henly, Wyman, & Gaugler, 2011) . Focusing research on individuals' symptom trajectories, rather than on symptoms at a single point in time, is a patient-centered approach and is highly relevant to clinical situations (Henly, Wyman, & Findorff, 2011) .
Trajectories of both fatigue and vital exhaustion have been identified in patients with ACS after discharge (Fennessy et al., 2010; Smith, Kupper, Denollet, & de Jonge, 2011) . Different symptom trajectories have been associated with differences in disease-related outcomes: Severe and increasing vital exhaustion trajectories have been associated with a greater incidence of cardiac events than mild and decreasing trajectories in one study using latent class growth analysis (LCGA) (Smith et al., 2011) . In another study using regression analysis, symptom trajectories also varied by gender, with women often experiencing severe but improving fatigue, in contrast to men's moderate, persistent fatigue (Fennessy et al., 2010) .
Psychological symptoms, such as anxiety and depression, have also been shown to persist over time (Doyle, McGee, Delaney, Motterlini, & Conroy, 2011; Kaptein, de Jonge, van den Brink, & Korf, 2006; Murphy et al., 2014) . The findings have not been consistent across studies, however. Some found that symptoms varied between individuals but were largely stable over time (Doyle et al., 2011; Martens, Smith, Winter, Denollet, & Pedersen, 2008; van Beek et al., 2012) , whereas others found worsening depression trajectories and improving anxiety trajectories within individuals (Kaptein et al., 2006; Lane, Carroll, Ring, Beevers, & Lip, 2002; Murphy et al., 2014; Tisminetzky, Bray, Miozzo, Aupont, & McLaughlin, 2011) .
Although the evidence on post-ACS symptom trajectories is promising, the spectrum of potential ACS-related symptoms is diverse, and patients who rule in as well as those who rule out are affected. To our knowledge, post-ED trajectories of multiple physical symptoms potentially related to ACS have not yet been studied.
Growth Mixture Modeling of Symptom Trajectories
Existing research suggests that potential ACS symptoms vary among individuals based on combinations of characteristics such as age, gender, and diagnosis (Arslanian-Engoren et al., 2006; Canto et al., 2012; DeVon, Ryan, Rankin, & Cooper, 2010) . However, this body of evidence includes findings that are, at times, conflicting and of unclear clinical significance. Variable-centered techniques, such as regression and chi-square analysis, have been used to test for specific hypothesized group differences and interactions but cannot reveal previously unknown subgroups of individuals. Neither cross-sectional models nor standard growth models are able to effectively model the complex heterogeneity of potential ACS symptoms experienced by patients over time. As a result, this phenomenon remains poorly understood despite considerable research.
Growth mixture modeling (GMM) is used to analyze change over time and identify groups of individuals who change in similar ways (Muthén, 2004) . Unlike traditional growth curve modeling, GMM does not rely on the assumption that all individuals belong to a single population. Instead, parameters are allowed to vary across unobserved subpopulations, which are also known as "latent classes" (Muthén, 2004) . These groups are "latent" in that they are revealed by identifying similar patterns of change in the data rather than defined by known baseline characteristics (Muthén, 2004) . One important parameter of GMM models is the number of groups-which is determined by comparing the fit of models with different numbers of groups. Rather than a single mean trajectory, GMM models may include multiple mean trajectories representing the different patterns of change in these subgroups. GMM is uniquely suited to exploring heterogeneity in diverse populations where multiple change patterns may exist, as is the case with patients with potential ACS.
Conceptual Framework
A modified version of the theory of unpleasant symptoms served as the organizing framework for this study (Lenz, Pugh, Milligan, Gift, & Suppe, 1997) . This theory relates influencing factors, symptoms, and performance outcomes. Symptoms are conceptualized as multidimensional, including quality, intensity, distress, and timing. Timing is especially important to the conceptualization of symptom trajectories, so for this study, timing is extended to include not only initial occurrence but also change over time (Brant, Beck, & Miaskowski, 2010) .
METHODS

Design, Setting, and Sample
The present investigation was a secondary analysis of data from a larger observational, prospective study. Detailed methods of the parent study are published elsewhere (DeVon, Burke, Nelson, Zerwic, & Riley, 2014) . In the parent study, participants were recruited from the EDs of four academic medical centers and one community hospital located in the Midwest, Pacific Northwest, and Western United States. The convenience sample consisted of 1,005 patients who presented with symptoms suggestive of ACS. Patients were initially approached if they had an abnormal electrocardiogram or troponin T level and were identified by the triage nurse as potentially having ACS. Other inclusion criteria were symptoms on presentation to the ED, age greater than 21 years, ability to speak English, telephone access, and intact cognition. One site, located in the Southwestern United States, also included Spanish speakers. Exclusion criteria included heart failure exacerbation (B-type natriuretic peptide > 500 ng/ml), referral to the ED from a dialysis center, and referral for cardiac dysrhythmia. Data collection occurred during the initial ED visit with follow-up telephone calls at 30 days and 6 months. The respective institutional review boards at each site approved the study.
Data Collection
The EDs were staffed with trained research assistants (RAs) between 8 and 16 hours per day (between 7:00 A.M. and 11:00 P.M.). Initial data collection occurred as soon as possible after arrival. After the patients' initial stabilization (i.e., vital signs were stable, and patients were treated with analgesics), RAs obtained written informed consent and administered questionnaires to collect symptom, clinical, and demographic data.
Measures
Demographic and Clinical Characteristics Baseline participant characteristics were assessed using the ACS Patient Information Questionnaire, which includes both demographic and clinical items. It was designed to capture all relevant data as outlined in the standardized reporting guidelines for ED patients with potential ACS, which are supported by the Society for Academic Medicine, the American College of Emergency Physicians, the American Heart Association, and the American College of Cardiology (Hollander et al., 2004) . Final diagnosis was based on the clinical judgment of the attending physicians (who were blinded to study data) and was abstracted from the medical record by trained RAs.
Symptoms Symptoms were assessed using the validated 13-item ACS Symptom Checklist, which was derived from the original Symptoms of Acute Coronary Syndrome Index (DeVon & Zerwic, 2003) . Each symptom is analyzed individually with no summary score. Symptom severity was scored from 0 = none to 10 = worst. After initial stabilization, participants were instructed to rate their current symptoms. At 30 days and 6 months, participants were instructed to rate symptoms experienced in the past week. Because of the subjective nature of symptom experiences, self-report is the most appropriate method of assessment. However, it is important to note that self-report of symptom severity may be influenced by patient factors such as prior symptom experiences.
Although data were collected for 13 symptoms as part of the parent study, only those symptoms reported by at least 25% of participants at any study time point (chest discomfort, chest pain, chest pressure, light-headedness, shortness of breath, shoulder pain, unusual fatigue, and upper back pain) were included in this secondary data analysis. The decision to limit included symptoms in this manner reflects both sample size limitations and the desire to generate a parsimonious, clinically useful set of models. Because symptom trajectories have not been described in this population, symptoms were analyzed individually for this exploratory study.
Time Time was coded in months for the analysis (0 = baseline, 1 = 30 days, and 6 = six months).
Statistical Analysis
Model Specification Preliminary analyses, including calculation of descriptive statistics, were carried out using SPSS (v.22) . Growth mixture models were estimated using Mplus software (v.7.11) with a robust maximum-likelihood estimator. Cases with missing symptom data for all three study time points (n = 3) were excluded from the analysis. Cases with partial data were retained, and missing data were handled using a fullinformation maximum-likelihood method (Muthén, 2004) .
For each of the eight symptoms, cases with a nonzero score (indicating symptom presence) at any point during the study period were included in that symptom's models. This choice reflects the focus on trajectories of symptom severity rather than probability of symptom occurrence. The resulting samples for each individual symptom model ranged from n = 725 to n = 816.
Linear change models (i.e., with the rate of change constant across time points) were estimated because the data were composed of three time points. Initially, models with growth factor variances fixed to zero (i.e., LCGA) were estimated (Nagin & Odgers, 2010) . LCGA is considered a special case of GMM and produces simpler models (Berlin, Parra, & Williams, 2014; Jung & Wickrama, 2008) . In subgroups identified using LCGA, the same model is used to describe change for each member, and differences among the members of a subgroup are regarded as error. In GMM, individual trajectories vary around class-specific mean trajectories for change. After LCGA models were estimated, more flexible GMMs with intercept variances freed were estimated. Models with between one and five latent classes were considered for each symptom. Both sample size limitations and clinical utility limit the interpretability of additional classes.
Model Selection For each symptom, models with increasing numbers of classes were systematically compared. Criteria were interpretability, parsimony, lowest adjusted Bayesian Information Criterion, significant Vuong-Lo-Mendell-Rubin likelihood ratio test, and class size greater than 5% of the sample based on most likely class membership (Wang & Bodner, 2007) . Bootstrap likelihood ratio tests were also computed for promising models (Nylund, Asparouhov, & Muthén, 2007) . Models with higher entropy and greater average posterior probability within each class were favored if other criteria were not decisive (Zaslavsky et al., 2014) .
Covariates Patient characteristics (age, gender, and diagnosis) were treated as potential covariates using a revised three-step procedure (model estimation, class assignment based on posterior probabilities, and logistic regression accounting for misclassification) (Vermunt, 2010) . The procedure was implemented by adding the variables of interest into the original model as auxiliary variables and using the "r3step" command in Mplus. The largest class for each symptom was used as the reference class. Each potential covariate was analyzed individually. There were no missing data for age or gender. Five cases had missing data for diagnosis and were excluded from further analysis based on the assumption that data were missing at random. This assumption is supported by the similarity of patients with complete and incomplete data based on available information.
RESULTS
Baseline Sample Characteristics
Demographic and clinical characteristics of the sample are shown in Table 1 . Most of the 1,002 included participants were White (70.5%), male (62.6%), and ruled out for ACS (57.1%) and had a mean age of 60.2 years (SD = 14.17 years).
Individual Symptom Severity
The most common symptoms experienced in the hospital after stabilization were chest discomfort (49.2%), chest pressure (47.8%), unusual fatigue (46.5%), chest pain (42.3%) shortness of breath (37.8%), light-headedness (35.6%), upper back pain (26.8%), and shoulder pain (25.8%). Mean symptom severity ranged from 1.71 to 3.32 after stabilization, 1.41 to 2.35 at 30 days, and 1.42 to 3.24 at 6 months (Table 2 ). Because baseline characteristics of patients with complete versus missing data were similar, missing symptom data at any time point were considered to be missing at random (i.e., not related to the missing values).
Final Model Selection
Model description and fit indices for each symptom's final model are shown in Table 3 . Fit statistics for rejected models are not included here because of the large number of models tested but are available (see Table, Supplemental Digital Content 1, http://links.lww.com/NRES/A178). For most symptoms, LCGA models with intercept and slope variance fixed to 0 were selected over less restrictive models based on the selection criteria defined above. For two symptoms (shortness of breath and shoulder pain), GMM models with intercept variance freely estimated were selected. Each symptom's final model included between two and four classes; no symptom was best modeled by a single trajectory class. Models with greater than four classes generally included at least one class too small to interpret (i.e., less than 5% of the sample).
Symptom Trajectories
Parameter estimates by class for each symptom's final model are shown in Table 4 , and the identified trajectory classes for each symptom are illustrated in Figure 1 . For four of the eight symptoms (chest discomfort, chest pain, chest pressure, and unusual fatigue), most participants were assigned to a class with an intercept less than 3.0 and a negative slope, a trajectory labeled "tapering off." Another common trajectory, defined by intercept close to 0 with a positive slope, was labeled "late onset/worsening" and was common in participants with upper back pain (66.7%), shoulder pain (69.3%), and shortness of breath (61.0%). A high percentage of participants with light-headedness (78.2%) and smaller percentages of patients with chest discomfort (20.4%), shoulder pain (11.8%), and unusual fatigue (16.7%) exhibited a "mild/persistent" trajectory with an intercept less than 3.0 and a relatively flat slope. A "moderate/worsening" trajectory, with an intercept between 2.5 and 5.0 and a positive slope, was found in a minority of patients with chest discomfort (10.2%), chest pain (15.2%), chest pressure (20.0%), and unusual fatigue (17.9%). A "severe/ improving" trajectory, characterized by an intercept greater than 8.0 and a negative slope, was identified in a small number of participants with shortness of breath (17.4%) and upper back pain (7.4%). Other uncommon trajectories identified included initially moderate symptoms that either decreased (improving) or remained stable (persistent).
Age, Gender, and Diagnosis as Predictors of Group Membership
Because prior research suggests that ACS symptoms vary based on age, gender, and diagnosis, these characteristics were treated as potential covariates. For each of the eight symptoms studied, trajectory classes differed significantly on at least one patient characteristic (Table 5) . Age was a significant predictor of trajectory membership for chest discomfort, light-headedness, shortness of breath, shoulder pain, and upper back pain. "Late-onset" and "tapering off" trajectories were most commonly predicted by older age. Female gender predicted more severe symptom trajectories for shoulder pain, unusual fatigue, and upper back pain. Diagnosis was a significant predictor of trajectory membership for every symptom except unusual fatigue. Non-ST-segment elevation MI (NSTEMI) diagnosis predicted "tapering off" or "late-onset" trajectories for most symptoms (chest discomfort, chest pain, chest pressure, shortness of breath, shoulder pain, and upper back pain). STelevation MI (STEMI) diagnosis also predicted "late-onset" trajectories for upper back pain, shoulder pain, and shortness of breath.
DISCUSSION
Increased Understanding of Symptom Trajectories
The findings of this secondary data analysis add support to existing evidence that patients experience ongoing symptoms after an ED visit for potential ACS (Barnason et al., 2012) . The Note. n = 1002. ACS = acute coronary syndrome; BMI = body mass index; HS = high school; NSTEMI = non-ST-segment elevation myocardial infarction; SD = standard deviation; STEMI = ST-segment elevation myocardial infarction; UA = unstable angina. Note. Findings are reported for participants who reported the symptom during the study period. SD = standard deviation.
analysis also reveals that individuals vary in both their initial symptom severity and rate and direction of change-a finding that has not been described in this population. Because the mean symptom severity scores for the entire sample fail to capture this heterogeneity, GMM is a valuable analytic tool for generating a more nuanced understanding. The identification of multiple, distinct classes of patients with different symptom trajectories is an initial step toward understanding how the symptom experience varies both among and within patients and thereby improving patient-centered care and symptom management. The examination of the individual trajectories within the symptom models is also revealing. The "tapering off" trajectory was common for chest symptoms and fits the expectation that symptoms generally improve over time after an acute period. The "late-onset/worsening" trajectory (observed for shortness of breath, shoulder pain, and upper back pain) and the "moderate/worsening" trajectory (seen in chest Symptom Trajectories After Emergency Department Visits discomfort, chest pain, chest pressure, and unusual fatigue) are more concerning. These patterns suggest that some patients experience unexpected new or worsening symptoms after their initial ED visit. Such patients may require more intensive follow-up to ensure symptom management and prevent unnecessary readmissions (Karlson et al., 1998) . Trajectories that are mild or moderate and persistent (found in chest discomfort, light-headedness, shortness of breath, shoulder pain, unusual fatigue, and upper back pain) are also noteworthy. Such unresolved symptoms reduce quality of life and may signify chronic, stable disease that requires treatment (Kim, Kim, & Hwang, 2015) . The finding that patient characteristics differ among symptom trajectories is clinically important. The same characteristics (younger age, female gender, and less likelihood of non-STEMI diagnosis) tended to predict membership in smaller, less typical classes across different symptoms regardless of the morphology of these trajectories. Patients with these characteristics may, therefore, be less likely to receive appropriate education and treatment than their peers with more common symptom trajectories.
Generating Hypotheses for Future Research
The unique approach of including all patients with similarly distressing symptoms, rather than including only patients with a confirmed ACS diagnosis, is patient centered rather than disease centered. Future patient-centered studies may build on our findings by evaluating distal outcomes of different symptom trajectories (e.g., health service use and quality of life) and testing interventions to reduce symptom burden based on differing symptom trajectories. The statistical techniques used in this study may also be used to identify symptom trajectories in other clinical and disease contexts.
Informing Patient Education
Patients presenting to the ED with symptoms suggestive of ACS, but who go on to be ruled out, are a population that has been understudied in previous research. These patients utilize significant healthcare resources but may be undertreated in the current disease-focused model of care. Our findings support the notion that follow-up is important for these patients as well as for patients who ruled in for ACS. All patients should be encouraged to track and report their ongoing and recurrent symptoms to ensure that they receive adequate medical treatment and symptom management plans.
Prediction of symptom trajectories based on information observable at initial presentation is also important to patient education. Patient characteristics associated with late-onset, persistent, or worsening trajectories may be seen as "red flags" for identifying at-risk patients. These patients may be targeted for individualized education, postdischarge support, and symptom management plans.
Limitations
Because symptom severity data were collected at only three time points, only linear models could be estimated. On the basis of our findings that distinct trajectory classes can be identified, future studies should be designed to allow comparison of model fit for higher-order and piecewise models by including more time points. Such models may represent symptom trajectories with greater nuance and accuracy. This study is also limited by the available sample: although large, the sample includes a higher proportion of patients who ruled in for ACS than other studies of this population. The parent study's primary aims required an adequate number of patients ruled in for ACS, and the resulting recruitment decisions led to underrepresentation of ruled out patients relative to the population of interest. Because multiple models were estimated in this analysis, there is the potential for overfitting to the sample. Therefore, these results should be verified in other samples. Finally, analysis of antecedents and consequences of symptom trajectories and the interaction of multiple symptoms were beyond the scope of this exploratory analysis but may generate clinically useful information in future studies.
Conclusions and Implications
Evidence of individuals' distinct symptom trajectories in the 6 months after an ED visit for potential ACS has the potential to improve patient education and clinical assessment of ongoing symptoms. Continued research on the individual nature of symptom trajectories may thus support patient-centered care. Symptom trajectory research can also contribute to the further development of symptom theory by expanding empirical evidence about the temporal aspects of symptom experiences. Future studies are needed to verify the existence of multiple symptoms trajectories in diverse populations, to assess the antecedents and consequences of individual symptom trajectories, and to examine relationships among different symptoms.
